Taiwan · Delayed Price · Currency is TWD Level Biotechnology Statistics
Total Valuation
TPEX:3118 has a market cap or net worth of TWD 1.10 billion. The enterprise value is 881.54 million.
| Market Cap | 1.10B |
| Enterprise Value | 881.54M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Jun 12, 2025 |
Share Statistics
TPEX:3118 has 32.45 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 32.45M |
| Shares Outstanding | 32.45M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 27.72% |
| Owned by Institutions (%) | n/a |
| Float | 22.46M |
Valuation Ratios
The trailing PE ratio is 14.22.
| PE Ratio | 14.22 |
| Forward PE | n/a |
| PS Ratio | 1.53 |
| PB Ratio | 1.84 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | 32.74 |
| P/OCF Ratio | 17.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.97, with an EV/FCF ratio of 26.31.
| EV / Earnings | 11.43 |
| EV / Sales | 1.23 |
| EV / EBITDA | 7.97 |
| EV / EBIT | 9.87 |
| EV / FCF | 26.31 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.11 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.24 |
| Interest Coverage | 488.23 |
Financial Efficiency
Return on equity (ROE) is 13.11% and return on invested capital (ROIC) is 17.89%.
| Return on Equity (ROE) | 13.11% |
| Return on Assets (ROA) | 6.73% |
| Return on Invested Capital (ROIC) | 17.89% |
| Return on Capital Employed (ROCE) | 14.67% |
| Weighted Average Cost of Capital (WACC) | 5.56% |
| Revenue Per Employee | 5.61M |
| Profits Per Employee | 602,727 |
| Employee Count | 128 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 4.64 |
Taxes
In the past 12 months, TPEX:3118 has paid 18.87 million in taxes.
| Income Tax | 18.87M |
| Effective Tax Rate | 19.65% |
Stock Price Statistics
The stock price has increased by +5.63% in the last 52 weeks. The beta is 0.24, so TPEX:3118's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +5.63% |
| 50-Day Moving Average | 33.43 |
| 200-Day Moving Average | 33.17 |
| Relative Strength Index (RSI) | 59.11 |
| Average Volume (20 Days) | 25,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:3118 had revenue of TWD 718.58 million and earned 77.15 million in profits. Earnings per share was 2.38.
| Revenue | 718.58M |
| Gross Profit | 262.07M |
| Operating Income | 89.35M |
| Pretax Income | 96.02M |
| Net Income | 77.15M |
| EBITDA | 106.40M |
| EBIT | 89.35M |
| Earnings Per Share (EPS) | 2.38 |
Balance Sheet
The company has 223.26 million in cash and 7.89 million in debt, with a net cash position of 215.37 million or 6.64 per share.
| Cash & Cash Equivalents | 223.26M |
| Total Debt | 7.89M |
| Net Cash | 215.37M |
| Net Cash Per Share | 6.64 |
| Equity (Book Value) | 597.47M |
| Book Value Per Share | 18.41 |
| Working Capital | 249.13M |
Cash Flow
In the last 12 months, operating cash flow was 63.90 million and capital expenditures -30.40 million, giving a free cash flow of 33.50 million.
| Operating Cash Flow | 63.90M |
| Capital Expenditures | -30.40M |
| Depreciation & Amortization | 16.88M |
| Net Borrowing | -4.70M |
| Free Cash Flow | 33.50M |
| FCF Per Share | 1.03 |
Margins
Gross margin is 36.47%, with operating and profit margins of 12.43% and 10.74%.
| Gross Margin | 36.47% |
| Operating Margin | 12.43% |
| Pretax Margin | 13.36% |
| Profit Margin | 10.74% |
| EBITDA Margin | 14.81% |
| EBIT Margin | 12.43% |
| FCF Margin | 4.66% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 6.51%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 6.51% |
| Dividend Growth (YoY) | 5.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 75.72% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 6.44% |
| Earnings Yield | 7.03% |
| FCF Yield | 3.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 5, 2011. It was a forward split with a ratio of 1.04999999.
| Last Split Date | Aug 5, 2011 |
| Split Type | Forward |
| Split Ratio | 1.04999999 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |